Online Business

Glenmark Generics gets US FDA nod for Ciclopirox Olamine

Glenmark Generics today said it has received ANDA (abbreviated new drug application) approval from the United States Food and Drug Administration for Ciclopirox Olamine cream, used in the treatment of dermatological infections. - Glenmark Pharma net dips 31% - Glenmark Pharma Q2 net dips 31% to Rs 81 cr - Glenmark Generics aims to raise Rs 570 cr through IPO - Glenmark Generics files IPO prospectus with Sebi - Glenmark raises Rs 413 cr in QIP - Glenmark plans to raise Rs 300-350 cr through QIP The company will start marketing and distribution of the product in the US market, a press release issued here said. Glenmark Generics (GGL) is a subsidiary of Glenmark Pharmaceuticals Ltd. Ciclopirox Olamine cream is the generic equivalent of Loprox cream marketed by Medicis. The product generated USD 8 million sales in the 12-month period ended September 2009. The broad-spectrum anti-fungal is indicated for the topical treatment of dermatological infections. Glenmark has 46 ANDAs pending approval with the US FDA, the release said, adding "GGL continues to identify and explore external development partnerships to supplement and accelerate the growth of the existing pipeline and portfolio."


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
SBI Life: Catch 'em young
Life insurers have begun to spend big money on brand promotion. The market, after all, is crowded. At last count, there were 22 companies in the fray for a market estimated at Rs 55,355 crore. SBI Life, the 74:26 venture of State Bank of India and BNP Paribas Assurance, has been not as aggressive as its rivals so far as brand promotion is concerned. Where others rolled out campaign after campaign, SBI Life stuck to its old campaigns. It is only now, after a two-year hiatus, that it has come out with a brand new advertising campaign.
Popular Articles
payday loans no faxing

Asthma, inflammatory drugs to cost Asthma, inflammatory drugs to cost Press Trust of India / New Delhi December 15, 2009, 20:17 IST
Sensex ends up 35pts

In search of history
Meghnad Desai admits in the preface that it is an ambitious book. Written by “someone who cannot claim to be a professional historian”, the book is the author’s own and “somewhat opinionated” account of how India became a nation. In the process, it outlines a new premise based on which Indians should “rediscover” the new India.